UBS Group’s Reunion Neuroscience Inc. Common Shares REUN Stock Holding History

UBS Group’s Portfolio REUN Stock Details REUN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-25	Closed	-$28	–	10308
2023 Q2	$28	Sell	25 -2,360	-99%	-$2K	﹤0.01%	8663
2023 Q1	$1.65K	Buy	2,385 +2,054	+621%	+$2.29K	﹤0.01%	8683
2022 Q4	$298	Sell	331 -4,523	-93%	-$6.59K	﹤0.01%	10261
2022 Q3	$7K	Buy	4,854 +4,230	+678%	+$15K	﹤0.01%	8947
2022 Q2	$3K	Buy	+624	New	+$3.12K	﹤0.01%	9434
2022 Q1	–	Sell	-900	Closed	-$11K	–	11246
2021 Q4	$11K	Buy	+900	New	+$19.3K	﹤0.01%	8715

UBS Group's REUN Position: Q3 2023 in Review

UBS Group sold out of Reunion Neuroscience Inc. Common Shares (REUN) in Q3 2023, closing a stake of 25 shares — an estimated $28 sold.

UBS Group first reported a position in REUN in Q4 2021 and held it in 6 quarters. The position peaked at $11K in Q4 2021. 0 funds tracked by Wall St. Rank hold REUN as of Q3 2023.

UBS Group reported no remaining Reunion Neuroscience Inc. Common Shares position as of Q3 2023 after selling out during the quarter.
UBS Group sold 25 Reunion Neuroscience Inc. Common Shares shares in Q3 2023, an estimated $28.
UBS Group first reported a position in Reunion Neuroscience Inc. Common Shares in Q4 2021 and held it in 6 quarters.
UBS Group's Reunion Neuroscience Inc. Common Shares position peaked at $11K in Q4 2021.
0 funds tracked by Wall St. Rank held Reunion Neuroscience Inc. Common Shares as of Q3 2023.

Based on UBS Group's 13F filing for Q3 2023, filed 9 Nov 2023.